EverHint – Momentum Swing Pack – Top 82 Signals for Aug 19, 2026
Excerpt: 82 signals (from 95 total). Healthcare leads (64). price range $7-$1281. 2 with insider selling.
Market Context
Equity markets are trading in a constructive, low-volatility environment, with all three major indices posting modest gains and the VIX declining sharply to 14.89. A 6% drop in the fear gauge signals that options markets are pricing in reduced near-term uncertainty, which historically compresses intraday price ranges and lowers the "noise" that can trigger false breakouts. For breakout-oriented strategies — including Breakout Ultra Tight, Breakout Standard, and Explosive Volume Breakout — this environment is a double-edged sword: cleaner setups with less whipsaw risk, but also potentially thinner follow-through moves as volatility contracts.
The broad upward drift across the S&P 500, Nasdaq, and Dow Jones reflects a risk-on posture with relatively balanced participation, suggesting institutional money is not rotating aggressively out of any single segment. This steady, grind-higher tape tends to favor momentum and pullback strategies, as dips are being bought and trends remain intact. Aggressive Momentum and Pullback Standard signals in particular benefit from this type of orderly trending behavior, where mean-reversion entries can align with the prevailing directional bias rather than fighting it.
Healthcare's emergence as the top sector — generating the most signals among the 12 active strategies — points to a notable rotation dynamic worth monitoring. Defensive sector leadership can sometimes signal that sophisticated investors are quietly repositioning even while headline indices remain buoyant. With Quality Low Vol and Large Cap strategies also active in today's signal pool, there is a subtle undercurrent of risk management alongside the more aggressive setups, suggesting the market may be rewarding selectivity and sector discipline over broad-based speculation.
Sector Tech
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (2 of 2)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ESTC | Elastic N.V. | Technology | $87.34 | 1.00 | — | $9.1B |
| 2 | MSI | Motorola Solutions, Inc. | Technology | $480.84 | 0.00 | — | $79.8B |
Explosive Volume Breakout
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (4 of 4)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | IMNM | Immunome, Inc. | Healthcare | $29.82 | 1.00 | — | $2.9B |
| 2 | TGT | Target Corporation | Consumer Defensive | $159.03 | 0.57 | — | $72.2B |
| 3 | MRK | Merck & Co., Inc. | Healthcare | $152.22 | 0.43 | — | $376.0B |
| 4 | URGN | UroGen Pharma Ltd. | Healthcare | $50.29 | 0.00 | — | $2.5B |
Pullback Standard
Standard pullback setup - stocks that dipped below MA21 and reclaimed it. Indicates potential bounce/continuation after healthy pullback. Lower-risk entries in established uptrends.
Entry Criteria:
- Dipped below MA21
- Reclaimed MA21 on increased volume
- Volume surge above average
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (3 of 3)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | $1280.74 | 1.00 | — | $1206.1B |
| 2 | NTES | NetEase, Inc. | Communication Services | $127.25 | 0.35 | — | $81.2B |
| 3 | NUVB | Nuvation Bio Inc. | Healthcare | $7.26 | 0.15 | — | $2.5B |
Breakout Ultra Tight
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (8 of 8)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | TWST | Twist Bioscience Corpo... | Healthcare | $142.39 | 1.00 | — | $8.9B |
| 2 | IMNM | Immunome, Inc. | Healthcare | $29.82 | 0.86 | — | $2.9B |
| 3 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $27.79 | 0.71 | — | $2.9B |
| 4 | MRK | Merck & Co., Inc. | Healthcare | $152.22 | 0.57 | — | $376.0B |
| 5 | TGT | Target Corporation | Consumer Defensive | $159.03 | 0.33 | — | $72.2B |
| 6 | NDSN | Nordson Corporation | Industrials | $309.92 | 0.24 | — | $17.3B |
| 7 | URGN | UroGen Pharma Ltd. | Healthcare | $50.29 | 0.19 | — | $2.5B |
| 8 | NUVB | Nuvation Bio Inc. | Healthcare | $7.26 | 0.00 | — | $2.5B |
Aggressive Momentum
Triple threat: high momentum + high volume + high volatility. Maximum momentum with high risk/reward. For aggressive traders seeking the strongest momentum setups.
Entry Criteria:
- High RSI momentum
- High volume surge
- High volatility
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: High
📊 Signals (4 of 4)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | TWST | Twist Bioscience Corpo... | Healthcare | $142.39 | 1.00 | — | $8.9B |
| 2 | IMNM | Immunome, Inc. | Healthcare | $29.82 | 0.67 | — | $2.9B |
| 3 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $27.79 | 0.33 | — | $2.9B |
| 4 | URGN | UroGen Pharma Ltd. | Healthcare | $50.29 | 0.00 | — | $2.5B |
Sector Healthcare
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (15 of 17)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ZLAB | Zai Lab Limited | Healthcare | $26.72 | 1.00 | — | $3.0B |
| 2 | TWST | Twist Bioscience Corpo... | Healthcare | $142.39 | 0.94 | — | $8.9B |
| 3 | HAE | Haemonetics Corporation | Healthcare | $108.41 | 0.88 | — | $4.9B |
| 4 | DXCM | DexCom, Inc. | Healthcare | $89.88 | 0.81 | — | $33.9B |
| 5 | RGEN | Repligen Corporation | Healthcare | $176.36 | 0.75 | — | $10.0B |
| 6 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $27.79 | 0.62 | — | $2.9B |
| 7 | PTGX | Protagonist Therapeuti... | Healthcare | $154.94 | 0.62 | — | $10.0B |
| 8 | IMNM | Immunome, Inc. | Healthcare | $29.82 | 0.56 | — | $2.9B |
| 9 | ORKA | Oruka Therapeutics, Inc. | Healthcare | $109.69 | 0.50 | Sell -$279,154 | $6.6B |
| 10 | MRK | Merck & Co., Inc. | Healthcare | $152.22 | 0.44 | — | $376.0B |
| 11 | A | Agilent Technologies, ... | Healthcare | $155.40 | 0.37 | — | $43.9B |
| 12 | PCVX | Vaxcyte, Inc. | Healthcare | $63.30 | 0.31 | — | $9.1B |
| 13 | URGN | UroGen Pharma Ltd. | Healthcare | $50.29 | 0.25 | — | $2.5B |
| 14 | LLY | Eli Lilly and Company | Healthcare | $1280.74 | 0.19 | — | $1206.1B |
| 15 | RCUS | Arcus Biosciences, Inc. | Healthcare | $30.35 | 0.12 | — | $3.8B |
Insider selling (7d): ORKA (-$279,154)
Breakout Standard
Stocks within 3% of 52-week high - standard breakout momentum setups. Stock showing strong momentum near or at highs. Increased volume confirms institutional interest. Breaking out or consolidating near resistance.
Entry Criteria:
- Strong RSI momentum
- Volume surge above average
- Within 3% of 52-week high
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (15 of 26)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ZLAB | Zai Lab Limited | Healthcare | $26.72 | 0.99 | — | $3.0B |
| 2 | TWST | Twist Bioscience Corpo... | Healthcare | $142.39 | 0.92 | — | $8.9B |
| 3 | HAE | Haemonetics Corporation | Healthcare | $108.41 | 0.88 | — | $4.9B |
| 4 | DXCM | DexCom, Inc. | Healthcare | $89.88 | 0.84 | — | $33.9B |
| 5 | RGEN | Repligen Corporation | Healthcare | $176.36 | 0.80 | — | $10.0B |
| 6 | ESTC | Elastic N.V. | Technology | $87.34 | 0.78 | — | $9.1B |
| 7 | APA | APA Corporation | Energy | $43.45 | 0.77 | — | $15.4B |
| 8 | IMNM | Immunome, Inc. | Healthcare | $29.82 | 0.68 | — | $2.9B |
| 9 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $27.79 | 0.64 | — | $2.9B |
| 10 | MT | ArcelorMittal S.A. | Basic Materials | $74.59 | 0.63 | — | $56.8B |
| 11 | PTGX | Protagonist Therapeuti... | Healthcare | $154.94 | 0.60 | — | $10.0B |
| 12 | CHYM | Chime Financial, Inc. ... | Financial Services | $33.07 | 0.58 | Sell -$5,392,545 | $12.6B |
| 13 | MRK | Merck & Co., Inc. | Healthcare | $152.22 | 0.55 | — | $376.0B |
| 14 | ORKA | Oruka Therapeutics, Inc. | Healthcare | $109.69 | 0.51 | Sell -$279,154 | $6.6B |
| 15 | TGT | Target Corporation | Consumer Defensive | $159.03 | 0.39 | — | $72.2B |
Insider selling (7d): ORKA (-$279,154), CHYM (-$5,392,545)
Volatile High Beta
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (9 of 9)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | HTFL | Heartflow, Inc. Common... | Healthcare | $45.53 | 0.96 | — | $3.9B |
| 2 | TWST | Twist Bioscience Corpo... | Healthcare | $142.39 | 0.84 | — | $8.9B |
| 3 | CHYM | Chime Financial, Inc. ... | Financial Services | $33.07 | 0.74 | Sell -$5,392,545 | $12.6B |
| 4 | ORKA | Oruka Therapeutics, Inc. | Healthcare | $109.69 | 0.71 | Sell -$279,154 | $6.6B |
| 5 | AMLX | Amylyx Pharmaceuticals... | Healthcare | $38.60 | 0.50 | — | $4.3B |
| 6 | PSNL | Personalis, Inc. | Healthcare | $15.81 | 0.37 | — | $1.7B |
| 7 | EWTX | Edgewise Therapeutics,... | Healthcare | $46.44 | 0.25 | — | $5.0B |
| 8 | NUVB | Nuvation Bio Inc. | Healthcare | $7.26 | 0.12 | — | $2.5B |
| 9 | SLS | SELLAS Life Sciences G... | Healthcare | $13.85 | 0.00 | — | $2.6B |
Insider selling (7d): ORKA (-$279,154), CHYM (-$5,392,545)
Quality Low Vol
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (7 of 7)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | MRK | Merck & Co., Inc. | Healthcare | $152.22 | 0.95 | — | $376.0B |
| 2 | MSI | Motorola Solutions, Inc. | Technology | $480.84 | 0.42 | — | $79.8B |
| 3 | TGT | Target Corporation | Consumer Defensive | $159.03 | 0.32 | — | $72.2B |
| 4 | PR | Permian Resources Corp... | Energy | $23.02 | 0.27 | — | $19.3B |
| 5 | NDSN | Nordson Corporation | Industrials | $309.92 | 0.22 | — | $17.3B |
| 6 | BHP | BHP Group Limited | Basic Materials | $92.29 | 0.12 | — | $234.4B |
| 7 | LLY | Eli Lilly and Company | Healthcare | $1280.74 | 0.05 | — | $1206.1B |
Cap Large Only
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (12 of 12)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | MRK | Merck & Co., Inc. | Healthcare | $152.22 | 0.92 | — | $376.0B |
| 2 | APA | APA Corporation | Energy | $43.45 | 0.82 | — | $15.4B |
| 3 | DXCM | DexCom, Inc. | Healthcare | $89.88 | 0.70 | — | $33.9B |
| 4 | MT | ArcelorMittal S.A. | Basic Materials | $74.59 | 0.69 | — | $56.8B |
| 5 | CHYM | Chime Financial, Inc. ... | Financial Services | $33.07 | 0.55 | Sell -$5,392,545 | $12.6B |
| 6 | MSI | Motorola Solutions, Inc. | Technology | $480.84 | 0.53 | — | $79.8B |
| 7 | TGT | Target Corporation | Consumer Defensive | $159.03 | 0.42 | — | $72.2B |
| 8 | NDSN | Nordson Corporation | Industrials | $309.92 | 0.34 | — | $17.3B |
| 9 | A | Agilent Technologies, ... | Healthcare | $155.40 | 0.33 | — | $43.9B |
| 10 | PR | Permian Resources Corp... | Energy | $23.02 | 0.24 | — | $19.3B |
| 11 | BHP | BHP Group Limited | Basic Materials | $92.29 | 0.06 | — | $234.4B |
| 12 | LLY | Eli Lilly and Company | Healthcare | $1280.74 | 0.03 | — | $1206.1B |
Insider selling (7d): CHYM (-$5,392,545)
Pullback Large Cap
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (2 of 2)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | $1280.74 | 0.30 | — | $1206.1B |
| 2 | NTES | NetEase, Inc. | Communication Services | $127.25 | 0.00 | — | $81.2B |
Sector Financial
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | CHYM | Chime Financial, Inc. ... | Financial Services | $33.07 | 0.00 | Sell -$5,392,545 | $12.6B |
Insider selling (7d): CHYM (-$5,392,545)
Field Notes
Sector concentration: Healthcare (64), Technology (6), Consumer Defensive (5)
Insider selling (7d): ORKA (Oruka Therapeutics, Inc., -$279,154), CHYM (Chime Financial, Inc. Class A Common Stock, -$5,392,545)
Data coverage: 2.1% insider (7d), 0.0% congressional (30d), 0.0% earnings, 3.2% news (7d)
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (64 signals) suggests sector-specific rotation.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.